Sufentanil Infusion vs Sufentanil Bolus

University of Nebraska65 enrolled

Overview

Randomized single blind controlled clinical trial to test the benefit of sufentanil infusion over bolus dosing to reduce time to extubation and reduced length of ICU stay.

This study will compare Sufentanil bolus vs infusion and analyze which has a faster extubation time in participants who undergo routine cardiac surgery. The hypothesis is that routine cardiac surgery patients receiving sufentanil infusion will have a lower sufentanil concentration at the end of surgery and have a shorter time to extubation than participants receiving sufentanil bolus dosing even with similar total doses of sufentanil. The intervention will be Sufentanil infusion during surgery and evaluations will include Sufentanil blood concentrations, ICU and hospital length of stay and re-intubation rate. We will follow up with the participants through their ICU stay (primary objective) and hospital length of stay (secondary objective).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Anesthesia

Interventions

Sufentanil InfusionDRUG

Intra-operative sufentanil infusion

Sufentanil BolusDRUG

Intra-operative sufentanil bolus

Eligibility

Sex: ALLMin age: 19 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Scheduled non-emergency cardiac surgical patients including those with planned procedures of CABG, AVR, and combined CABG and AVR * 19 to 80 years old * Planned pre-operative anesthesia screening visit and/or preoperative surgical clinic visit. * Inpatient subject that is scheduled (greater than 24hrs in advance) for a non-emergency cardiac surgical case Exclusion Criteria: * Sufentanil allergy * EF less than or equal to 30% * Moderate or severe right ventricular dysfunction, * Moderate pulmonary dysfunction, to include patients with at home 02 and/or daily bronchodilator therapy. * End Stage Renal Disease on Dialysis * Chronic Kidney Disease with GFR \<30 * Sternotomy Re-do * Emergency surgery * Greater than 4 units of RBCs or FFP combined * Mechanical circulatory support post-operatively such as ECMO, IABP, Impella * Not eligible for rapid wean extubation protocol * Requires infusion of sedative medication required during ICU admission * Greater than or equal to 15 minute ICU hold within PACU

Locations (1)

University of Nebraska Medical Center

Omaha, Nebraska, United States

Outcomes

Primary Outcomes

Time to Extubation

We will determine if sufentanil infusion administration intra-operatively during routine cardiac surgery will decrease time to extubation from OR stop data collection time point by 60 minutes compared to sufentanil bolus administration.

Time frame: Amount of time in minutes from procedure finish to time of extubation, up to 800 minutes.

Secondary Outcomes

Plasma Concentration

We will determine if sufentanil infusion administration intra-operatively during routine cardiac surgery will result in a lower plasma concentration of sufentanil at time of arrival to ICU and if the plasma concentration correlates with time to extubation.

Time frame: Lab concentration is drawn when patient arrives to ICU, an average of 1 hour after procedure.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.